- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/112 - SalmonellaShigella
Patent holdings for IPC class A61K 39/112
Total number of patents in this class: 561
10-year publication summary
|
40
|
32
|
30
|
41
|
46
|
33
|
27
|
34
|
26
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1597 |
40 |
| University of Maryland, Baltimore | 1054 |
28 |
| Board of Trustees of the University of Arkansas | 825 |
12 |
| University of Florida Research Foundation, Inc. | 4154 |
10 |
| Bharat Biotech International Limited | 84 |
10 |
| Centre National de La Recherche Scientifique | 10895 |
9 |
| Children's Medical Center Corporation | 1933 |
8 |
| The Cleveland Clinic Foundation | 1586 |
8 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3331 |
8 |
| Prokarium Limited | 36 |
8 |
| Indian Council of Medical Research | 61 |
7 |
| Institut Pasteur | 787 |
7 |
| The Texas a & M University System | 1848 |
7 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2976 |
7 |
| The General Hospital Corporation | 4832 |
6 |
| Arizona Board of Regents on behalf of Arizona State University | 2864 |
6 |
| Intervet Inc. | 920 |
6 |
| Najit Technologies, Inc. | 13 |
6 |
| National Research Council of Canada | 1539 |
6 |
| University of Kansas | 913 |
6 |
| Other owners | 356 |